You are here

Home / Resources / Key Material
Export 133 results:
Filters: First Letter Of Last Name is F  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
R
Michen, B., Diatta A., Fritsch J., Aneziris C., & Graule T. (2011).  Removal of colloidal particles in ceramic depth filters based on diatomaceous earth. Separation and Purification Technology. 81(pp. 77-87), 
Timms, S., Slade J., & Fricker C. (1995).  Removal of Cryptosporidium by Slow Sand Filtration. Water Science and Technology. 3,
Timms, S., Slade J., & Fricker C. (1995).  Removal of Cryptosporidium by Slow Sand Filtration. Water Science and Technology. 3,
Gray, G. C., Callahan J. D., Hawksworth A. W., Fisher C. A., & Gaydos J. C. (1999).  Respiratory diseases among US military personnel: countering emerging threats.. Emerging infectious diseases. 5, 379.
DuPont, H.. L., Hornick R.. B., Dawkins A.. T., Snyder M.. J., & Formal S.. B. (1969).  The Response of Man to Virulent Shigella flexneri 2a. Journal of Infectious Diseases. 119, 3.
Slovic, P.., Finucane M.. L., Peters E.., & MacGregor D.. G. (2004).  Risk as analysis and risk as feelings: some thoughts about affect, reason, risk, and rationality. Risk analysis: an official publication of the Society for Risk Analysis. 24, 2.
Friedman, CR. (2004).  Risk factors for sporadic Campylobacter infection in the United States: a case -control study in FoodNet sites.
Fischhoff, B.. (1995).  Risk perception and communication unplugged: twenty years of process. Risk analysis: an official publication of the Society for Risk Analysis. 15, 2.
Kaplowitz, L.. G., Fischer J.. J., & Sparling P.. F. (1981).  Rocky Mountain spotted fever: a clinical dilemma. Curr. Clin. Top. Infect. Dis. 2, 89-108.
DuPont, HL., Hornick RB., Dawkins AT., Heiner GG., Fabrikant IB., Jr CL. Wisseman, et al. (1973).  Rocky Mountain spotted fever: a comparative study of the active immunity induced by inactivated and viable pathogenic Rickettsia rickettsii. Journal of Infectious Diseases. 128, 340–344.
Tacket, C. O., Sztein M. B., Losonsky G., Abe A., Finlay B. B., McNamara B. P., et al. (2000).  Role of EspB in Experimental Human Enteropathogenic Escherichia coli Infection. Infection and Immunity. 68, 6.
Tacket, C. O., Sztein M. B., Losonsky G., Abe A., Finlay B. B., McNamara B. P., et al. (2000).  Role of EspB in Experimental Human Enteropathogenic Escherichia coli Infection. Infection and Immunity. 68, 6.
S
Boyle, E. C., Bishop J. L., Grassl G. A., & Finlay B. B. (2007).  Salmonella: from pathogenesis to therapeutics. Journal of Bacteriology. 189(5), 
Andoh, M.., Naganawa T.., Hotta A.., Yamaguchi T.., Fukushi H.., Masegi T.., et al. (2003).  SCID Mouse Model for Lethal Q Fever. Infection and Immunity. 71, 8.
Jr, A. B. Boehm, Ashbolt N. J., Jr J. M. Colford, Dunbar L. E., Fleming L. E., Gold M. A., et al. (2009).  A sea change ahead for recreational water quality criteria. Journal of Water and Health. 7, 9–20.
Muniesa, M., Simon M., Prats G., & Ferrer D. (2003).  Shiga toxin 2-converting bacteriophages associated with clonal variability in Escherichia coli O157:H7 strains of human origin isolated from a single outbreak.
Frenkel, J. K., Frenkel J. K., & Chinchilla M. (1975).  Soil survival of toxoplasma oocysts in Kansas and Costa Rica. The American Society of Tropical Medicine and Hygiene. 24,
Frenkel, J. K., Frenkel J. K., & Chinchilla M. (1975).  Soil survival of toxoplasma oocysts in Kansas and Costa Rica. The American Society of Tropical Medicine and Hygiene. 24,
Gaudart, J., Rebaudet S., Barrais R., Boncy J., Faucher B., Piarroux M., et al. (2013).  Spatio-temporal dynamics of cholera during the first year of the epidemic in Haiti. PLoS neglected tropical diseases. 7, e2145.
Beer, K. D., Gargano J. W., Roberts V. A., Hill V. R., Garrison L. E., Kutty P. K., et al. (2015).  Surveillance for waterborne disease outbreaks associated with drinking water—United States, 2011–2012. MMWR Morb Mortal Wkly Rep. 64, 842–8.
T
Matthews, J., Dickey B., Miller R., & Felzer J. (2012).  The epidemiology of published norovirus outbreaks: a review of risk factors associated with attack rate and genogroup.
DuPont, H. L., Hornick R. B., Dawkins A. T., Snyder M. J., & Formal S. B. (1969).  The Response of Man to Virulent Shigella flexneri 2a. The Journal of Infectious Diseases. 119, 296–299.
Dubey, J. P., Navarro I. T., Sreekumar C., Dahl E., Freire R. L., Kawabata H. H., et al. (2004).  Toxoplasma gondii infections in cats from Paraná, Brazil: seroprevalence, tissue distribution, and biologic and genetic characterization of isolates. The Journal of Parasitology. 90,
Fan, S., Deng G., Song J., Tian G., Suo Y., Jiang Y., et al. (2009).  Two amino acid residues in the matrix protein M1 contribute to the virulence difference of H5N1 avian influenza viruses in mice. Virology.. 384, 1.
Bieber, D., Ramer S. W., C-y W., Murray W. J., Tobe T., Fernandez R., et al. (1998).  Type IV Pili, Transient Bacterial Aggregates, and Virulence of Enteropathogenic Escherichia coli. Science.. 280, 5372.